Dermtech, INC
Market Movers (8-K)
DMTKQ
Dermtech, INCDermTech, Inc. will be delisted from the Nasdaq Capital Market after filing for Chapter 11 bankruptcy.
Worse than expected
DMTKQ
Dermtech, INCDermTech has filed for Chapter 11 bankruptcy protection and is reducing its workforce by approximately 20% as part of a strategic restructuring.
Worse than expected
DMTKQ
Dermtech, INCDermTech is being sued by its landlord for $661,706.34 in unpaid rent, potentially impacting the company's financial stability.
Worse than expected
DMTKQ
Dermtech, INCDermTech's first-quarter 2024 results show increased revenue and reduced losses, driven by higher average selling prices and cost-cutting measures.
Better than expected
Capital raise
DMTKQ
Dermtech, INCDermTech, Inc. has received a notice of potential default on its office lease due to $661,706 in unpaid rent, which could have a material adverse effect on the company's finances.
Worse than expected
DMTKQ
Dermtech, INC8-K: DermTech Announces Restructuring and Strategic Alternatives Exploration Amidst Workforce Reduction
DermTech is implementing a restructuring plan, including a 56% workforce reduction, while exploring strategic alternatives to maximize stockholder value.
Worse than expected
Capital raise
Quarterly Earnings (10-Q)
DMTKQ
Dermtech, INCDermTech's Q1 2024 revenue increased slightly to $3.8 million, but the company faces substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
Annual Reports (10-K)
DMTKQ
Dermtech, INCDermTech has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
Delay expected
DMTKQ
Dermtech, INCDermTech, Inc.'s 10-K filing details the company's common stock and related governance, including anti-takeover provisions and share structure.